Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gastrointestinal tumors
Biotech
GSK goes East again, snagging option on DualityBio ADC for $30M
GSK has made another trip to China for an ADC, returning with an option on a preclinical DualityBio candidate that could ultimately cost $1 billion.
Nick Paul Taylor
Dec 4, 2024 8:20am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am
Gilead stops phase 3 TIGIT trial, doubles down on other studies
Jan 30, 2024 8:09am
Gilead-Arcus' TIGIT gets high response in gastric cancer
Nov 7, 2023 9:40am
Alimentiv, Summit Clinical partner to improve research on NASH
Nov 10, 2022 5:03am
IDRx nabs $122M to address precision medicine 'whack-a-mole'
Aug 2, 2022 6:30am
